Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
J-POST: Thalidomide for Crow-Fukase (POEMS) Syndrome
jRCT1091220046Completed
- Sponsor
- J-POST Clinical Trial Office
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in osteosclerotic myeloma (POEMS) comparing Thalidomide (FPF 300) with Placebo (FPF 300 placebo) (2 arms). Primary endpoint: Reduction rate of serum VEGF level. Started Sep 2010; status: completed.
02
Drugs
thalidomide
03
Conditions
osteosclerotic myeloma (POEMS)
Beyond the preview
Go deeper on jRCT1091220046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1091220046.